Related Experiment Video

Updated: Nov 3, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.8K

MLN4924 inhibits cell proliferation by targeting the activated neddylation pathway in endometrial carcinoma

Huanrong Liu1, Qiaoli Bei1, Xiaoqian Luo1

  • 1Department of Gynaecology, Shanghai First Maternity and Infant Hospital, Tongji University, Shanghai, China.

The Journal of International Medical Research
|June 4, 2021
PubMed
Abstract

Insights

The neddylation pathway is overactive in endometrial cancer. Its specific inhibitor, MLN4924, shows potential as a therapeutic drug by suppressing cancer cell growth and inducing cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The neddylation pathway is frequently activated in various cancers.
  • Endometrial carcinoma is a prevalent malignancy of the female reproductive system.

Purpose of the Study:

  • To investigate the neddylation pathway as a therapeutic target in endometrial carcinoma.
  • To evaluate the efficacy of the neddylation inhibitor MLN4924 in endometrial cancer models.

Main Methods:

  • Analysis of The Cancer Genome Atlas data for neddylation gene expression.
  • Validation of gene expression using RT-PCR and Western blots.
  • In vitro studies using endometrial cancer cell lines treated with MLN4924.

Main Results:

  • Significant overexpression of UBC12, UBE2F, RBX1, and RBX2 in endometrial carcinoma tissues.
  • UBE2F and RBX2 expression correlated positively with patient survival.
  • MLN4924 inhibited proliferation and colony formation, induced DNA re-replication, cell cycle arrest, and apoptosis.
  • MLN4924 treatment led to the accumulation of cullin-RING ligase substrates.

Conclusions:

  • The neddylation pathway plays a critical role in endometrial cancer development.
  • MLN4924 demonstrates potential as a targeted therapeutic agent for endometrial carcinoma.
Keywords:
Endometrial cancerMLN4924apoptosiscell cycle arrestcullin-RING ligaseneddylation

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.2K
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.4K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K